Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Juvenile Diabetes Research Foundation | OTHER |
| Canadian Institutes of Health Research (CIHR) | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
The goal of this interventional study is to assess the effects and evaluate the implementation of a pediatric to adult care transition intervention in youth with T1D on clinical, patient-reported, and implementation outcomes, including an economic analysis.
The 3 main aims are:
Researchers will compare a pre-intervention cohort to evaluate the impact of the transition coordinator intervention.
Both usual care and intervention groups will receive routine diabetes care as per Canadian national guidelines. Usual care (routine care) includes regular appointments with their pediatric diabetes care team (i.e., pediatric endocrinologist, diabetes nurse or dietician) and post-transfer with their adult diabetes team (i.e., physician and as needed visits with a diabetes educator and/or a dietician). The transition process usually starts at age 14 with discussions during clinic with youth and families around increased autonomy, self-care, organization of adult healthcare services and specific transition topics such as driving, drugs, alcohol, relationships, finances and living away from home.
The usual care group is defined as the group who receives usual care and serves as the control group. This group is defined prior to the implementation of the intervention. We include a two month wash out period between our two groups to avoid care providers 'holding on' to patients they feel may benefit from the intervention.
The intervention group (in addition to usual care) is provided additional support by way of a non-medical transition coordinator during the transition and transfer from pediatric to adult diabetes care. The non-medical transition coordinator encourages problem solving, self-management skills, and supports navigating the 'adult world'. In the year prior to transfer, the transition coordinator will meet each participant in person or virtually once during their routine pediatric diabetes appointment to explain their role prior to transfer. The transition coordinator role includes the following tasks: (1) use of text messaging, email, or phone communication (as per participant's preference) to maintain contact with the participant every 2 months for 12 months past the transfer date; (2) use of text messaging, email, or telephone as needed when participants reach out to them to answer any questions whereby the transition coordinator would provide direction; (3) assisting participants with finding family physicians (if needed); (4) assisting with completion of financial assistance, disability, insurance forms; (4) addressing any stated psychosocial needs by relaying information on community supports for participants and families; and, (5) maintaining a private Facebook® page and a transition website in which participants were encouraged to use. Website contents include information on transition, adult diabetes care (i.e., location, contact numbers, what to expect in adult care), diabetes resources as well as mental health resources. The website will be updated to have information relevant to each implementation site. We may add other types of social media to share information about transition (i.e., TikTok, Instagram), and this will be considered during our pre-implementation phase. The transition coordinator will not provide any medical advice or counselling.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Usual Care Group | No Intervention | No intervention group used as a control leading into the intervention for comparative analysis. Patients in this arm receive care as usual with no changes and are not aware of the intervention group. | |
| Intervention Group | Experimental | Patients in this arm receive access to and support from a Transition coordinator who will meet with them prior to transition from pediatric to adult care and follow up with them every 2 months throughout the first year of their transition period utilizing phone, text, email, social media. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Non-Medical Transition Coordinator | Other | Participants in this intervention arm will have access to the non-medical transition coordinator to support their transition from pediatric to adult care. |
| Measure | Description | Time Frame |
|---|---|---|
| Lost to Followup | % of participants who are lost to follow up as defined by not attending at least one routine clinic visit in adult diabetes care with a health care professional to be ascertained from physician billing claims or NACRS claims data | within 1 year of transfer date from pediatric care |
| Measure | Description | Time Frame |
|---|---|---|
| Patient Reported Outcome Survey 1 | Problem Areas in Diabetes - Teen version Survey | within 2 months of transfer from pediatric care, repeated at 12 months after transfer |
| Patient Reported Outcome Survey 2 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
-
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sonia Butalia, MD | University of Calgary | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Alberta Children's Hospital | Calgary | Alberta | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003922 | Diabetes Mellitus, Type 1 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
The usual care group is defined as the group who receives usual care and serves as the control group. This group is defined prior to the implementation of the intervention. We include a two month wash out period between our two groups to avoid care providers 'holding on' to patients they feel may benefit from the intervention
Not provided
Not provided
Not provided
Not provided
Diabetes Self-Efficacy Survey
| within 2 months of transfer from pediatric care, repeated at 12 months after transfer |
| Patient Reported Outcome Survey 3 | Diabetes Quality of Life for Youth Survey (short version) | within 2 months of transfer from pediatric care, repeated at 12 months after transfer |
| Clinical Outcome 1 | mean total number of clinic visits with any health care professional collected from NACRS claims data and physician claims data | one year prior to transfer from pediatric care up to 18 months post transfer |
| Clinical Outcome 2 | total number of diabetes related emergency department visits and hospitalizations for diabetic ketoacidosis | one year prior to transfer from pediatric care up to 18 months post transfer |
| Clinical outcome 3 | mean HbA1c | one year prior to transfer from pediatric care up to 18 months post transfer |
| Clinical outcome 4 | total number of HbA1c tests completed | one year prior to transfer from pediatric care up to 18 months post transfer |
| Clinical Outcome 5 | mean urinary albumin:creatinine ratio | one year prior to transfer from pediatric care up to 18 months post transfer |
| Clinical Outcome 6 | total number of urinary albumin:creatinine ratio tests completed | one year prior to transfer from pediatric care up to 18 months post transfer |
| D004700 | Endocrine System Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |